HRB
65
-5
TROW
48
-3
EXC
61
-2
AMAT
57
3
MCO
70
-3
STI
75
29
VIX
44
-8
DFS
62
-5
FLR
55
2
WMB
70
2
EQT
64
4
AMG
36
-7
WHR
35
-11
IFF
44
-3
DD
46
-2
HAL
53
5
NTAP
60
4
SNA
53
-2
CNX
63
-4
VFC
13
-3
HRB
65
-5
TROW
48
-3
EXC
61
-2
AMAT
57
3
MCO
70
-3
STI
75
29
VIX
44
-8
DFS
62
-5
FLR
55
2
WMB
70
2
EQT
64
4
AMG
36
-7
WHR
35
-11
IFF
44
-3
DD
46
-2
HAL
53
5
NTAP
60
4
SNA
53
-2
CNX
63
-4
VFC
13
-3
Financhill
Back

Teva Pharmaceutical Industries Quote, Financials, Valuation and Earnings

He cracked the code to crypto

Now he says a new two-year bull market has begun. And he likes one altcoin above all others.
Sell
48

TEVA
Teva Pharmaceutical Industries

Last Price:
13.71
Seasonality Move:
1.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!

Act now for your path to extra income!

Teva Pharmaceutical Industries Price Quote

$13.71
+0.46 (+3.47%)
(Updated: April 26, 2024 at 12:30 PM ET)

Teva Pharmaceutical Industries Key Stats

Sell
48
Teva Pharmaceutical Industries (TEVA) is a Sell
Day range:
$12.80 - $13.30
52-week range:
$7.09 - $14.47
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.94
P/B ratio:
1.98%
Volume:
8.5M
Avg. volume:
8.4M
1-year change:
61%
Market cap:
$14.9B
Revenue:
$15.8B
EPS:
$-0.47

How Much Does Teva Pharmaceutical Industries Make?

Is Teva Pharmaceutical Industries Growing As A Company?

Teva Pharmaceutical Industries Stock Price Performance

What Is Teva Pharmaceutical Industries 52-Week High & Low?

Teva Pharmaceutical Industries Price To Free Cash Flow

Is It Risky To Buy Teva Pharmaceutical Industries?

Is Teva Pharmaceutical Industries Cash Flow Positive?

Teva Pharmaceutical Industries Return On Invested Capital

  • Is Management Doing A Good Job?
    TEVA return on invested capital is -1.96%
  • What Is Teva Pharmaceutical Industries Return On Assets?
    ROA measures how assets are converting to revenues and is -1.29%
  • What Is TEVA Return On Equity?
    ROE is a measure of profitability and is -6.89%

Teva Pharmaceutical Industries Earnings Date & Stock Price

Teva Pharmaceutical Industries Competitors

Teva Pharmaceutical Industries Dividend Yield

Data Unavailable

Teva Pharmaceutical Industries Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 31.74%
Revenue: 14.78% 11.15%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 15.74
Upside from Last Price: 18.76%

Major Shareholders

  • How many TEVA shares are owned by institutional investors?
    695M TEVA shares are owned by institutional investors
  • How many TEVA shares are owned by insiders?
    7.9M TEVA shares are owned by insiders